At the same time, an analysis of over 40,000 user comments posted on social media platforms has found that users of GLP-1 receptor agonists (including semaglutide) felt that the drugs have mixed effects on their mood, anxiety, and insomnia conditions [14]. This evidence concerns the gene GLP1R and insomnia.